PBS NewsHourLean L·
FDA panel backs first-of-its-kind flu vaccine using mRNA technology
The Food and Drug Administration is evaluating Moderna's new shot, dubbed mFlusiva, for older Americans ahead of the winter flu season.
Read at PBS NewsHour →
US · 1 sources covering this
FDA panel backs first-of-its-kind flu vaccine using mRNA technology
The Food and Drug Administration is evaluating Moderna's new shot, dubbed mFlusiva, for older Americans ahead of the winter flu season.
Coverage spectrum
1 L · 0 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/8df3512617d1790847d1cc4105bfbf9b83c55aae" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="FDA panel backs first-of-its-kind flu vaccine using mRNA technology"></iframe>
